Tirzepatide for Obesity in Adults ≥ 65 Years: A Post Hoc Analysis of the SURMOUNT and SUMMIT Clinical Trials.

Alfaris N, Kushner RF, Li J, Chen KL, Fenimore M, Calderon B, Stefanski A

Open source

DOI
10.1111/dom.70991
Published
2026 Sep
Container
Diabetes, obesity & metabolism
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/dom.70991,
  title = {Tirzepatide for Obesity in Adults ≥ 65 Years: A Post Hoc Analysis of the SURMOUNT and SUMMIT Clinical Trials.},
  author = {Alfaris N and Kushner RF and Li J and Chen KL and Fenimore M and Calderon B and Stefanski A},
  year = {2026},
  journal = {Diabetes, obesity \& metabolism},
  doi = {10.1111/dom.70991},
  url = {https://doi.org/10.1111/dom.70991}
}

RIS

TY  - JOUR
TI  - Tirzepatide for Obesity in Adults ≥ 65 Years: A Post Hoc Analysis of the SURMOUNT and SUMMIT Clinical Trials.
AU  - Alfaris N
AU  - Kushner RF
AU  - Li J
AU  - Chen KL
AU  - Fenimore M
AU  - Calderon B
AU  - Stefanski A
PY  - 2026
JO  - Diabetes, obesity & metabolism
DO  - 10.1111/dom.70991
UR  - https://doi.org/10.1111/dom.70991
ER  - 

APA

N, A., RF, K., J, L., KL, C., M, F., B, C., & A, S. (2026). Tirzepatide for Obesity in Adults ≥ 65 Years: A Post Hoc Analysis of the SURMOUNT and SUMMIT Clinical Trials.. Diabetes, obesity & metabolism. https://doi.org/10.1111/dom.70991

Source records